Untreated asymptomatic bacteriuria has been associated with acute pyelonephritis, which may have a role in many maternal and fetal complications. Acute pyelonephritis in pregnancy is related to anemia, septicemia, transient renal dysfunction, and pulmonary insufficiency. A randomized study was conducted to assess the clinical and microbiological efficacy of a single dose of fosfomycin trometamol for the treatment of asymptomatic bacteriuria in the second trimester of pregnancy compared with a 5-day regimen of cefuroxime axetyl. Forty-four women received fosfomycin trometamol and 40 women received cefuroxime axetyl. There were no statistically significant differences between both groups regarding the mean age and mean duration of pregnancy. Therapeutic success was achieved in 93.2% of the patients treated with fosfomycin trometamol vs 95% of those treated with cefuroxime axetyl. A single dose of fosfomycin trometamol is a safe and effective alternative in the treatment of asymptomatic urinary tract infections in the second trimester of pregnancy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00192-006-0190-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- * Timely diagnosis and appropriate antibacterial therapy (ABT) are essential for preventing adverse outcomes, with treatment varying based on the severity of the UTI; severe cases may require hospitalization and intravenous medications, while milder cases can be treated with oral drugs.
- * For uncomplicated UTIs in pregnant women, effective oral ABT options include nitrofurans, fosfomycin trometamol, and third-generation cephalosporins, particularly cefixime, which is
Introduction: Chronic recurrent cystitis is a common and difficult problem of modern urology. Traditional use of antimicrobial drugs often cannot lead to the long-term remission.
Aim: To evaluate the efficacy and safety of using different dosages and routes of the drug Superlymph in rectal and vaginal suppositories 10 U and 25 U in patients with chronic recurrent cystitis.
[Experience with UroBest in patients with acute cystitis].
Urologiia
September 2024
A.I. Burnazyan SRC FMBC, FMBA of Russia, Moscow, Russia.
Aim: To evaluate the efficacy and safety of UroBest complex in sachets for combined therapy of patients with acute cystitis in comparison with products of similar composition.
Materials And Methods: The randomized multi-center study included 90 patients with acute cystitis aged 18 to 49 years who were treated at the clinical bases of SRC FMBC, FMBA of Russia, Moscow, Russia, Altai State Medical University and Voronezh State Medical University named after N.N.
Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin.
Urol Int
October 2024
Departement of Urology, Caritas St. Josef Medical Center Regensburg, University of Regensburg, Regensburg, Germany.
Introduction: According to guidelines, transrectal random biopsy of the prostate (TRBP) is performed under antibiotic prophylaxis (AP). Fosfomycin-trometamol (FOS) is not approved in Germany, but TRBP as indication was listed in the product information falsely. The aim was to investigate infectious complications of TRBP under FOS as a single dose.
View Article and Find Full Text PDFComparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
World J Urol
May 2024
Department of Urology, Cantonal Hospital Aarau, Tellstrasse 25, 5001, Aarau, Switzerland.
Article Synopsis
- - The study assessed the effectiveness of different antibiotic prophylaxis regimens for transrectal prostate biopsies after the EMA recommended changes, comparing ciprofloxacin, fosfomycin trometamol (FMT), and a combination of FMT with trimethoprim/sulfamethoxazole (TMP/SMX).
- - A total of 822 men participated, with infection rates observed at 5% for ciprofloxacin, 13.2% for fosfomycin alone, and just 2.1% for the combination therapy.
- - The findings suggest that fosfomycin alone increased infection rates significantly, while the combined regimen of FMT and TMP/SMX showed similar safety and efficacy levels as ciprof
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!